His lab is engaged on refining the alanine-scanning assay to a few critical residues that can precisely distinguish amongst fibrils from neurodegenerative tauopathies. He envisions working with this streamlined assay for postmortem neuropathological prognosis, And maybe for blood screening of tauopathies.They shown this marriage with the two pathol